Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, CereportBORLONGAN, C. V; EMERICH, D. F.Brain research bulletin. 2003, Vol 60, Num 3, pp 297-306, issn 0361-9230, 10 p.Article

Effect of Vitreoscilla Hemoglobin and Culture Conditions on Production of Bacterial L-Asparaginase, an Oncolytic EnzymeERENLER, Sebnem O; GECKIL, Hikmet.Applied biochemistry and biotechnology. 2014, Vol 173, Num 8, pp 2140-2151, issn 0273-2289, 12 p.Article

Antimicrobials in beekeepingREYBROECK, Wim; DAESELEIRE, Els; DE BRABANDER, Hubert F et al.Veterinary microbiology (Amsterdam). 2012, Vol 158, Num 1-2, pp 1-11, issn 0378-1135, 11 p.Article

Immunomodulation in cancer therapeuticsEHRKE, M. Jane.International immunopharmacology. 2003, Vol 3, Num 8, pp 1105-1119, issn 1567-5769, 15 p.Article

Apoptosis and melanoma chemoresistanceSOENGAS, Maria S; LOWE, Scott W.Oncogene (Basingstoke). 2003, Vol 22, Num 20, pp 3138-3151, issn 0950-9232, 14 p.Article

PAC1 is a direct transcription target of E2F-1 in apoptotic signalingWU, J; JIN, Y. J; CALAF, G. M et al.Oncogene (Basingstoke). 2007, Vol 26, Num 45, pp 6526-6535, issn 0950-9232, 10 p.Article

A novel Bcl-x splice product, Bcl-X_AK, triggers apoptosis in human melanoma cells without BH3 domainHOSSINI, A. M; GEILEN, C. C; FECKER, L. F et al.Oncogene (Basingstoke). 2006, Vol 25, Num 15, pp 2160-2169, issn 0950-9232, 10 p.Article

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelVAN HASSELT, J. G. C; VAN CALSTEREN, K; HEYNS, L et al.Annals of oncology. 2014, Vol 25, Num 10, pp 2059-2065, issn 0923-7534, 7 p.Article

Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivoYUK FAI TO; SUN, Raymond Wai-Yin; YONGXIONG CHEN et al.International journal of cancer (Print). 2009, Vol 124, Num 8, pp 1971-1979, issn 0020-7136, 9 p.Article

Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelatorRONG ZHAO; PLANALP, Roy P; RONG MA et al.Biochemical pharmacology. 2004, Vol 67, Num 9, pp 1677-1688, issn 0006-2952, 12 p.Article

PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survivalCAMERON, Angus J; PROCYK, Katarzyna J; LEITGES, Michael et al.International journal of cancer. 2008, Vol 123, Num 4, pp 769-779, issn 0020-7136, 11 p.Article

Two-color Raman spectroscopy for the simultaneous detection of chemotherapeutics and antioxidative status of human skinWERNCKE, W; LATKA, I; SASSNING, S et al.Laser physics letters (Print). 2011, Vol 8, Num 12, pp 895-900, issn 1612-2011, 6 p.Article

Oncogramme, A New Promising Method for Individualized Breast Tumour Response Testing for Cancer TreatmentGIRAUD, S; LOUM, E; BESSETTE, B et al.Anticancer research. 2011, Vol 31, Num 1, pp 139-145, issn 0250-7005, 7 p.Article

Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cellsEICHELE, K; RAMER, R; HINZ, B et al.Oncogene (Basingstoke). 2008, Vol 27, Num 21, pp 3032-3044, issn 0950-9232, 13 p.Article

Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducerATTARDI, Laura D; DE VRIES, Annemieke; JACKS, Tyler et al.Oncogene (Basingstoke). 2004, Vol 23, Num 4, pp 973-980, issn 0950-9232, 8 p.Article

Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agentsMAYHEW, Christopher N; PERKIN, Lisa M; XIAOPING ZHANG et al.Oncogene (Basingstoke). 2004, Vol 23, Num 23, pp 4107-4120, issn 0950-9232, 14 p.Article

Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cellsMARTIN, V; SANCHEZ-SANCHEZ, A. M; HERRERA, F et al.British journal of cancer. 2013, Vol 108, Num 10, pp 2005-2012, issn 0007-0920, 8 p.Article

Therapeutic nanoparticles in clinics and under clinical evaluationSCHÜTZ, Cathering A; JUILLERAT-JEANNERET, Lucienne; MUELLER, Heinz et al.Nanomedicine (London. Print). 2013, Vol 8, Num 3, pp 449-467, issn 1743-5889, 19 p.Article

Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular contextDEAN, J. L; MCCLENDON, A. K; STENGEL, K. R et al.Oncogene (Basingstoke). 2010, Vol 29, Num 1, pp 68-80, issn 0950-9232, 13 p.Article

Cyclin Bl is an efficacy-predicting biomarker for Chkl inhibitorsZHAN XIAO; JOHN XUE; GU, Wen-Zhen et al.Biomarkers (London. Print). 2008, Vol 13, Num 6, pp 579-596, issn 1354-750X, 18 p.Article

Chemotherapeutics and hormesisCALABRESE, Edward J; BALDWIN, Linda A.Critical reviews in toxicology. 2003, Vol 33, Num 3-4, pp 305-353, issn 1040-8444, 49 p.Article

Hair loss pattern due to chemotherapy-induced anagen effluvium : A cross-sectional observationSOOK JUNG YUN; KIM, Seong-Jin.Dermatology (Basel). 2007, Vol 215, Num 1, pp 36-40, issn 1018-8665, 5 p.Article

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacyYU, Y; RAHMANTO, Y. Suryo; RICHARDSON, D. R et al.British journal of pharmacology. 2012, Vol 165, Num 1, pp 148-166, issn 0007-1188, 19 p.Article

SERIALITY AND STANDARDIZATION IN THE PRODUCTION OF 606 = Sérialité et standardisation dans la production du 606HÜNTELMANN, Axel C.History of science. 2010, Vol 48, Num 161, pp 435-460, issn 0073-2753, 26 p., 3-4Article

Effect of chronic vincristine treatment on mechanical withdrawal response and pre-pulse inhibition in the ratBORZAN, Jasenka; LAGRAIZE, Stacey C; FUCHS, Perry N et al.Neuroscience letters. 2004, Vol 364, Num 2, pp 110-113, issn 0304-3940, 4 p.Article